Autopsy and Case Reports
https://autopsyandcasereports.org/article/doi/10.4322/acr.2019.100
Autopsy and Case Reports
Article / Clinical Case Report

Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum

Matheus Dalben Fiorentino; Jean Michel Correia Monteiro; Renata Elisie Barbalho de Siqueira; Elizabeth Im Myung Kim; Ana Paula Curi; Cristiane Rubia Ferrreira; Mirella Nardo; Fernando Peixoto Ferraz de Campos

Downloads: 1
Views: 202

Abstract

Primary splenic angiosarcoma (PSA) is a rare neoplasm of vascular origin associated with aggressive behavior and poor prognosis. The clinical presentation is usually non-specific and is mostly characterized by a wasting disease with anemia and splenomegaly, mimicking a wide range of entities. The authors present the case of an 80-year-old woman with cardiovascular comorbidities with a 6-month history of weight loss, fatigue, weakness, pallor, and abdominal pain. The physical examination showed massive splenomegaly and pallor. After a thorough evaluation that ruled out lymphoproliferative diseases, the working diagnosis was a myelodysplastic disorder. A few days after discharge, she returned to the emergency room with severe abdominal pain, worsening fatigue, and a remarkable pallor. Point-of-care ultrasound showed free intraperitoneal fluid. Spleen rupture was confirmed by abdominal computed tomography (CT) scan, and an emergency laparotomy with splenectomy was performed. The postoperative period was uneventful, and the patient recovered in a few days. The histopathology confirmed the diagnosis of PSA and the patient was referred to an oncological center. Two months later staging CT demonstrated liver and peritoneal metastases, and despite the chemotherapy she died 6 months after the diagnosis.

Keywords

Splenic Diseases, Splenomegaly, Hemangiosarcoma, Splenic Rupture

References

Xu L, Zhang Y, Zhao H, Chen Q, Ma W, Li L. Well-differentiated angiosarcoma of spleen: a teaching case mimicking hemangioma and cytogenetic analysis with array comparative genomic hybridization. World J Surg Oncol. 2015;13(1):300. [https://doi.org/10.1186/s12957-015-0716-1]. [PMID:26462621]

Hamid KS, Rodriguez JA, Lairmore TC. Primary splenic angiosarcoma. JSLS. 2010;14(3):431-5. [https://doi.org/10.4293/108680810X12924466006521]. [PMID:21333203]

Thompson WM, Levy AD, Aguilera NS, Gorospe L, Abbott RM. Angiosarcoma of the spleen: imaging characteristics in 12 patients. Radiology. 2005;235(1):106-15. [https://doi.org/10.1148/radiol.2351040308]. [PMID:15749977]

Li R, Li M, Zhang LF, et al. Clinical characteristics and prognostic factors of primary splenic angiosarcoma: a retrospective clinical analysis from China. Cell Physiol Biochem. 2018;49(5):1959-69. [https://doi.org/10.1159/000493656]. [PMID:30235449]

Azevedo OS, Santos BN, Liboni NS, Costa JF, Campos OD. Splenic angiosarcoma: a diagnostic splenectomy finding. Case Rep Oncol. 2016;9(3):733-7. [https://doi.org/10.1159/000452619]. [PMID:27920710]

Langhans T. Pulsirende cavernöse Geschwulst der Milz mit metastatischen Knoten in der Leber. Tödtlicher Verlauf binnen 5 Monaten. Arch Pathol Anat Physiol Klin Med. 1879;75(2):273-91. [https://doi.org/10.1007/BF02134657].

Falk S, Krishnan J, Meis JM. Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol. 1993;17(10):959-70. [https://doi.org/10.1097/00000478-199310000-00001]. [PMID:8372948]

Shukla M, Shukla VK, Basu S, Kumar M. Fever, anemia and splenomegaly: a rare presentation of splenic angiosarcoma. Indian J Med Paediatr Oncol. 2011;32(4):230-2. [https://doi.org/10.4103/0971-5851.95148]. [PMID:22563160]

Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11(10):983-91. [https://doi.org/10.1016/S1470-2045(10)70023-1]. [PMID:20537949]

Kohutek F, Badik L, Bystricky B. Primary angiosarcoma of the spleen: rare diagnosis with atypical clinical course. Case Rep Oncol Med. 2016;2016:4905726. [https://doi.org/10.1155/2016/4905726]. [PMID:27867672]

Takato H, Iwamoto H, Ikezu M, Kato N, Ikarashi T, Kaneko H. Splenic hemangiosarcoma with sinus endothelial differentiation. Acta Pathol Jpn. 1993;43(11):702-8. [PMID:8310831]

Neuhauser TS, Derringer GA, Thompson LDR, et al. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. Mod Pathol. 2000;13(9):978-87. [https://doi.org/10.1038/modpathol.3880178]. [PMID:11007038]

Yang KF, Li Y, Wang DL, Yang JW, Wu SY, Xiao WD. Primary splenic angiosarcoma with liver metastasis: a case report and literature review. World J Gastroenterol. 2016;22(12):3506-10. [https://doi.org/10.3748/wjg.v22.i12.3506]. [PMID:27022233]

Deng R, Chang W, Wu X, Chen J, Tao K, Zhang P. Primary splenic angiosarcoma with fever and anemia: a case report and literature review. Int J Clin Exp Pathol. 2015;8(11):14040-4. [PMID:26823717]

Coppola S, Leva A, Pagni F, Famularo S, Gianotti L. Demanding diagnosis of splenic angiosarcoma as cause of delayed treatment of spontaneous splenic rupture: a case report and literature review. Case Rep Surg. 2017;2017:6256102. [https://doi.org/10.1155/2017/6256102]. [PMID:28261515]

Serrano OK, Knapp E, Huang K, et al. Pediatric primary splenic angiosarcoma: an aggressive multidisciplinary approach to the oncologic management of a rare malignancy. World J Surg Oncol. 2014;12(1):379. [https://doi.org/10.1186/1477-7819-12-379]. [PMID:25487642]

Badiani R, Schaller G, Jain K, Swamy R, Gupta S. Angiosarcoma of the spleen presenting as spontaneous splenic rupture: a rare case report and review of the literature. Int J Surg Case Rep. 2013;4(9):765-7. [https://doi.org/10.1016/j.ijscr.2013.06.007]. [PMID:23856255]

Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996;61(3):170-6. [https://doi.org/10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8]. [PMID:8637202]

Chen KT, Bolles JC, Gilbert EF. Angiosarcoma of the spleen: a report of two cases and review of the literature. Arch Pathol Lab Med. 1979;103(3):122-4. [PMID:581838]

Aqil B, Green LK, Lai S. Primary splenic angiosarcoma associated with anemia, leukocytosis and thrombocytopenia. Ann Clin Lab Sci. 2014;44(2):217-21. [PMID:24795063]

Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics. 2004;24(4):1137-63. [https://doi.org/10.1148/rg.244045006]. [PMID:15256634]

Thompson WM, Levy AD, Aguilera NS, Gorospe L, Abbott RM. Angiosarcoma of the spleen: imaging characteristics in 12 patients. Radiology. 2005;235(1):106-15. [https://doi.org/10.1148/radiol.2351040308]. [PMID:15749977]

Valbuena JR, Levenback C, Mansfield P, Liu J. Angiosarcoma of the spleen clinically presenting as metastatic ovarian cancer. A case report and review of the literature. Ann Diagn Pathol. 2005;9(5):289-92. [https://doi.org/10.1016/j.anndiagpath.2005.03.007]. [PMID:16198958]

Hsu JT, Chen HM, Lin CY, et al. Primary angiosarcoma of the spleen. J Surg Oncol. 2005;92(4):312-6. [https://doi.org/10.1002/jso.20419]. [PMID:16299797]

Duan YF, Jiang Y, Wu CX, Zhu F. Spontaneous rupture of primary splenic angiosarcoma: a case report and literature review. World J Surg Oncol. 2013;11(1):53. [https://doi.org/10.1186/1477-7819-11-53]. [PMID:23497454]

Singh P, Sharma S, Gupta P, Lal A, Srinivasan R. Primary splenic angiosarcoma with liver metastasis: a rare neoplasm diagnosed on fine-needle aspiration cytology and cell block immunocytochemistry. J Cytol. 2018;35(2):114-6. [https://doi.org/10.4103/JOC.JOC_148_16]. [PMID:29643660]

Casper ES, Waltzman RJ, Schwartz GK, et al. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest. 1998;16(7):442-6. [https://doi.org/10.3109/07357909809011697]. [PMID:9774950]

Zwi LJ, Evans DJ, Wechsler AL, Catovsky D. Splenic angiosarcoma following chemotherapy for follicular lymphoma. Hum Pathol. 1986;17(5):528-30. [https://doi.org/10.1016/S0046-8177(86)80044-2]. [PMID:3516861]

Hara T, Tsurumi H, Kasahara S, et al. Long-term survival of a patient with splenic angiosarcoma after resection, high-dose chemotherapy, and autologous peripheral blood stem cell transplantation. Intern Med. 2010;49(20):2253-7. [https://doi.org/10.2169/internalmedicine.49.3969]. [PMID:20962445]

Koontz BF, Miles EF, Rubio MA, et al. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies. Head Neck. 2008;30(2):262-6. [https://doi.org/10.1002/hed.20674]. [PMID:17685450]

Miura H, Asada Y. Treatment of eyelid lesion of angiosarcoma with facial artery recombinant interleukin-2 (rIL-2) injection. J Am Acad Dermatol. 2006;54(5):907-8. [https://doi.org/10.1016/j.jaad.2005.11.1047]. [PMID:16635681]

Takeuchi K, Deguchi M, Hamana S, Motoyama S, Kitazawa S, Maruo T. A case of postirradiation vaginal angiosarcoma treated with recombinant interleukin-2 therapy. Int J Gynecol Cancer. 2005;15(6):1163-5. [https://doi.org/10.1111/j.1525-1438.2005.00268.x]. [PMID:16343203]

Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer. 2005;104(2):361-6. [https://doi.org/10.1002/cncr.21140]. [PMID:15948172]

Amaya CN, Perkins M, Belmont A, et al. Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma. Oncoscience. 2018;5(3-4):109-19. [PMID:29854879]

 

 

 


Publication date:
07/12/2019

5d2880f40e8825165f3fe26f autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections